+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Cutaneous Lupus Erythematosus (CLE) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Cutaneous Lupus Erythematosus (CLE) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Antibody-Mediated Graft Rejection Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Antibody-Mediated Graft Rejection Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Thumbnail Image

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Janus Kinase (JAK) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • January 2024
  • 120 Pages
  • Global
From
Lupus Nephritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Lupus Nephritis - Epidemiology Forecast - 2032

  • Report
  • January 2024
  • 84 Pages
  • Global
From
SIMPONI Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SIMPONI Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Liposomal Cyclosporine A Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Liposomal Cyclosporine A Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Bertilimumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Bertilimumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
US Alopecia Areata - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Alopecia Areata - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • November 2023
  • 115 Pages
  • United States
From
Ulcerative Colitis (UC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ulcerative Colitis (UC) - Epidemiology Forecast - 2032

  • Report
  • August 2023
  • 147 Pages
  • Global
From
Alopecia Areata - U.S Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Alopecia Areata - U.S Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • June 2023
  • 115 Pages
  • United States
From
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Cutaneous Lupus Erythematosus - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Cutaneous Lupus Erythematosus - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 164 Pages
  • Global
From
JAK inhibitors - Competitive Landscape, 2023 - Product Thumbnail Image

JAK inhibitors - Competitive Landscape, 2023

  • Report
  • April 2023
  • 180 Pages
  • Global
From
COSENTYX Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

COSENTYX Emerging Drug Insight and Market Forecast - 2032

  • Report
  • March 2023
  • 30 Pages
  • Global
From
ENSPRYNG Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ENSPRYNG Emerging Drug Insight and Market Forecast - 2032

  • Report
  • March 2023
  • 30 Pages
  • Global
From
Androgenetic Alopecia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Androgenetic Alopecia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 134 Pages
  • Global
From
Androgenetic Alopecia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Androgenetic Alopecia - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 67 Pages
  • Global
From
Psoriatic Arthritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Psoriatic Arthritis - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 141 Pages
  • Global
From
LUPKYNIS Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LUPKYNIS Market Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more